Osendarp, S. J., van Raaij, J. M., Darmstadt, G. L., Baqui, A. H., Hautvast, J. G., and Fuchs, G. J. Zinc supplementation during pregnancy and effects on growth and morbidity in low birthweight infants:
a randomised placebo controlled trial.
Not exact matches
Medium - dose riboflavin as a prophylactic agent in children with migraine: a preliminary
placebo -
controlled,
randomised, double - blind, cross-over trial.
He contributes to other large - scale clinical trials including SAVE (evaluating whether treatment of obstructive sleep apnoea with continuous positive airways pressure can reduce the incidence of serious CV events in patients with established CVD), and CREDENCE, a
randomised, double - blind,
placebo -
controlled trial assessing whether canagliflozin can slow the progression of diabetic nephropathy in patients with type 2 diabetes.
Food additives and hyperactive behaviour in 3 - year - old and 8 / 9 - year - old children in the community: A
randomised, double - blinded,
placebo -
controlled trial.
Pre-specified subgroup analyses were performed.Six
randomised controlled trials were included in this IPDMA, encompassing data from 787 patients (n = 390 for nifedipine; n = 397 for
placebo / no treatment).
We searched PubMed, Embase, and Cochrane databases for
randomised controlled trials of maintenance tocolysis therapy with nifedipine in preterm labour.We selected trials including pregnant women between 24 and 36 (6/7) weeks of gestation (gestational age, GA) with imminent preterm labour who had not delivered after 48hours of initial tocolysis, and compared maintenance nifedipine tocolysis with
placebo / no treatment.The primary outcome was perinatal mortality.
Long - term treatment with probiotics in primary care patients with irritable bowel syndrome — a
randomised, double - blind,
placebo controlled trial.
Fred Hayden of the University of Virginia at Charlottesville says both Tamiflu and
placebo patients in the
randomised controlled trials were also on paracetamol (acetaminophen), so the two were indeed compared.
However, these studies are not
randomised controlled trials — the gold standard — in which people are randomly assigned
placebos or drugs.
Several
randomised,
placebo -
controlled studies show that these medications can reduce the frequency of migraine attacks, even though the majority of them were originally developed to treat other indications,» Prof Sprenger observed.
The study, «Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a
randomised, double - blind,
placebo -
controlled trail,» published online will change how clinicians understand this treatment and encourage them to consider its early use before the condition causes severe emphysema.
Dr David Wilkinson, of the University's School of Psychology, helped lead the
randomised, double - blinded,
placebo -
controlled trial.
The Maternal Vitamin D Osteoporosis Study (MAVIDOS) is the first
randomised,
placebo -
controlled trial designed to measure the impact of pregnancy vitamin D supplementation on the bone health of babies using bone density scanning.
However, the first Mayo trial, designed to be double - blind,
randomised,
placebo -
controlled research and purporting to have duplicated the conditions in Cameron's clinical trial, disproved the Cameron - Pauling thesis.
The gold standard in clinical trials is a
randomised,
placebo -
controlled study.
And it remains true that no homeopathic remedy has ever been shown to work in a large
randomised placebo -
controlled clinical trial.
This Phase 2a,
randomised, double - blind,
placebo -
controlled multicentre study included 149 active PsA patients.
BACKGROUND Whether endovascular stroke treatment improves clinical outcomes is unclear because of the paucity of data from
randomised placebo -
controlled trials.
Immunogenicity and safety of three consecutive production lots of the non replicating smallpox vaccine MVA: A
randomised, double blind,
placebo controlled phase III trial.
Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre,
randomised,
placebo -
controlled, phase 3 trial.
In this double - blind,
placebo -
controlled phase II study (NCT00848692), 30 CFS patients were
randomised to either Rituximab 500 mg / m2 or saline, given twice two weeks apart, with follow - up for 12 months.
We also performed subgroup meta - analyses by type of prevention (primary v secondary: in this study, trials involving healthy populations or patients with any specific disease except for cardiovascular disease were classified as primary prevention trials, and trials involving patients with cardiovascular disease were classified as secondary prevention trials), type of supplement by quality and dose (each supplement, vitamins only, antioxidants only, or antioxidants excluding vitamins), type of outcome (cardiovascular death, angina, fatal or non-fatal myocardial infarction, stroke, or transient ischaemic attack), type of outcome in each supplement, type of study design (
randomised, double blind,
placebo controlled trial v open label,
randomised controlled trial), methodological quality (high v low), duration of treatment (< 5 years v ≥ 5 years), funding source (pharmaceutical industry v independent organisation), provider of supplements (pharmaceutical industry v not pharmaceutical industry), type of
control (
placebo v no
placebo), number of participants (≥ 10000 v < 10000), and supplements given singly or in combination with other vitamin or antioxidant supplements by quality.
I did not conduct
randomised controlled placebo trials.
A double - blind
randomised -
controlled crossover trial was designed to measure the effects of oral curcumin versus
placebo on single - leg jump performance and DOMS following unaccustomed heavy eccentric exercise.
Another recent
randomised,
placebo -
controlled, single - blind trial comparing Curcumin with
placebo was designed to assess the muscle damage of healthy male volunteers after performing a 45 minute downhill running race.
The study was a double - blind,
randomised -
controlled crossover trial in which the Curcumin or
placebo were taken two days before to three days after eccentric exercise and the results found that only the Curcumin had beneficial effects.
Reduction of delayed onset muscle soreness by a novel curcumin delivery system (Meriva ®): a
randomised,
placebo -
controlled trial.
Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a
randomised placebo -
controlled trial.
Iodide induces thyroid autoimmunity in patients with endemic goitre: a
randomised, double - blind,
placebo -
controlled trial.
Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances: a
randomised, double blind,
placebo controlled study.
Kalliomäki, M et al; Probiotics in Primary Prevention of Atopic Disease: a
Randomised Placebo -
Controlled Trial:, The Lancet; April 2001; Volume 357, Issue 9262, Pages 1076 - 1079
Tielsch, J. M., Khatry, S. K., Stoltzfus, R. J., Katz, J., LeClerq, S. C., Adhikari, R., Mullany, L. C., Black, R., and Shresta, S. Effect of daily zinc supplementation on child mortality in southern Nepal: a community - based, cluster
randomised,
placebo -
controlled trial.
Bobat, R., Coovadia, H., Stephen, C., Naidoo, K. L., McKerrow, N., Black, R. E., and Moss, W. J. Safety and efficacy of zinc supplementation for children with HIV - 1 infection in South Africa: a
randomised double - blind
placebo -
controlled trial.
In a double - blind,
placebo -
controlled,
randomised trial, each subject consumed two capsules per d of either a
placebo or a LPR formulation (1 · 6 × 108 colony - forming units of LPR / capsule with oligofructose and inulin).
Efficacy of 12 weeks supplementation of a botanical extract - based weight loss formula on body weight, body composition and blood chemistry in healthy, overweight subjects — a
randomised double - blind
placebo -
controlled clinical trial
MRC / BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high - risk individuals: a
randomised placebo -
controlled trial
Sazawal, S., Black, R. E., Ramsan, M., Chwaya, H. M., Dutta, A., Dhingra, U., Stoltzfus, R. J., Othman, M. K., and Kabole, F. M. Effect of zinc supplementation on mortality in children aged 1 - 48 months: a community - based
randomised placebo -
controlled trial.
Effect of zinc supplementation on malaria and other causes of morbidity in west African children:
randomised double blind
placebo controlled trial.
Protocol for a
randomised controlled trial investigating the effectiveness of an online e-health application compared to attention
placebo or sertraline in the treatment of generalised anxiety disorder.
Individual or cluster
randomised controlled trials of any psychotherapy (PT) versus no treatment, attention -
placebo, waiting - list
control, or treatment as usual, in adolescents (aged 6 — 18 years) with depression or dysthymia.
Cognitive and motor skills in school - aged children following maternal vitamin A supplementation during pregnancy in rural Nepal: a follow - up of a
placebo -
controlled,
randomised cohort
With regard to pharmacological options for the treatment chronic irritability, the only
randomised controlled trial in children with SMD found no benefit of lithium over
placebo.
Wehmeier et al24 found QbTest to be a valid measure of treatment outcome and highly correlated with blinded observer ratings of behaviour in
placebo -
controlled randomised controlled trial (RCTs).
A comparative analysis of
randomised,
placebo -
controlled trials in youth BD established that atypical antipsychotics have better efficacy and tolerability compared with anticonvulsants and lithium (effect size atypical antipsychotics 0.65, CI 0.53 to 0.78 vs anticonvulsants and lithium 0.24, 95 % CI 0.06 to 0.41).
The review included
placebo controlled, double blind
randomised controlled trials (RCTs) of drug therapy for the neuropsychiatric symptoms of dementia, and meta - analyses of such RCTs.
The only long - term trial in youth with BD is a 30 - week,
randomised controlled trial showing that aripiprazole was superior to
placebo in improving mania symptoms at endpoint.5 However, completion rates were low (32.4 %), limiting the inferences that can be drawn about it.
Study selection and analysis:
Randomised controlled trials investigating psychological treatment compared to
control (waiting list, care as usual or
placebo) in adults (aged ≥ 18 years) with depression (according to diagnostic interview or self - report questionnaire) and which reported treatment effects on suicidal ideation or risk, or hopelessness.
Randomised controlled trials comparing agomelatine with
placebo in the treatment of unipolar major depression were systematically reviewed.